Wesley Almeida Souza

Dr. Wesley Almeida Souza

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Inorganica Chimica Acta
Verified
Journal Article
Closed access
LSLuana M. Sousa
Luana M. Sousa
WSWesley Almeida Souza
Wesley Almeida Souza
DPDrielly A. Paixão
Drielly A. Paixão
RFRodrigo B. Fazzi
Rodrigo B. Fazzi
DTDaiane Y. Tezuka
Daiane Y. Tezuka
WGWendell Guerra
Wendell Guerra

17 November 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
MLMeiry Leandra de Lacerda
Meiry Leandra de Lacerda
DRDaise A. Rossi
Daise A. Rossi
ELEduarda Cristina Lourenzatto
Eduarda Cristina Lourenzatto
MICAELA GUIDOTTI TAKEUCHIMICAELA GUIDOTTI TAKEUCHI
MICAELA GUIDOTTI TAKEUCHI
WSWesley Almeida Souza
Wesley Almeida Souza
RMRoberta Torres Melo
Roberta Torres Melo
This work describes the synthesis and characterization of two metal complexes of the type [M(L1)2(phen)], where M = Pt2+ (complex I) or Pd2+ (complex II), L1 = 5-amino-1,3,4-thiadiazole-2(3H)-thiolate and phen = 1,10-phenanthroline. The in vitro antibacterial activity of these complexes was investigated in isolation and synergistically with ciprofloxacin (CIP) and erythromycin (ERY) in three strains of Campylobacter jejuni (MIC = 32 mg/L for CIP and ERY), selected from a bank of 235 strains representative of three poultry exporting states of the country (A, B and C), previously analyzed for epidemiology and resistance to CIP and ERY. A total of 53/235 (22.55%) strains showed co-resistance to CIP and ERY. Isolated resistance to CIP was higher than to ERY. Epidemiological analysis showed that resistance to CIP was more evident in state B (p < 0.0001), as well as a higher susceptibility to ERY in state C (p = 0.0028). Co-resistance was expressive in state A and in the spring and fall seasons. The evaluation of I alone and in synergy with CIP and ERY found values up to 0.25 mg/L not significant for ERY. Complex II did not show an antimicrobial effect on the three strains of tested C. jejuni. The effect provided by complex I represents a promising alternative for control of resistant strains of C. jejuni.

1 January 2026 in Journal of the Brazilian Chemical Society
Verified
Journal Article
Closed access
BRBruna A. Rodrigues
Bruna A. Rodrigues
AAAngelina M. de Almeida
Angelina M. de Almeida
MAMauro V. de Almeida
Mauro V. de Almeida
JRJackson Antônio L. C. Resende
Jackson Antônio L. C. Resende
WGWendell Guerra
Wendell Guerra
WSWesley Almeida Souza
Wesley Almeida Souza
In this work, the trans-[Pt(L)2(PPh3)2] complex (L: 5-heptyl-1,3,4-oxadiazole-2-(3H)-thione) was associated with a microemulsion (ME/PtII complex). The microemulsified system underwent physicochemical characterization, including pH, conductivity, rheology, zeta potential, and dynamic light scattering (DLS) measurements. The microemulsion system remained stable at a pH near 6.0, indicating biocompatibility, while the conductivity was between 7 and 8 μS cm-1 , with a hysteresis area of −0.06 Pas-1 for the ME/PtII complex. The DLS technique confirmed the presence of a microemulsion with particle sizes ranging from 10 to 200 nm. The polydispersity index for the ME/PtII complex system was close to 0.3, indicating a monodisperse system, with a zeta potential of −19.2 ± 4.49 mV. These results showed that the system containing the PtII complex and the microemulsion is thermodynamically stable. Subsequently, cell viability studies demonstrated that the ME/PtII complex system is not toxic to peripheral blood mononuclear cells (PBMCs). In the phagocytosis activity assay, the complex associated with the microemulsion showed an increase in the phagocytosis index, suggesting that the microemulsion (ME/PtII complex) has potential for new biological assays, such as antitumor and antibacterial.